Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Mesenchymal Stem Cells-Derived Exosomes by Cellular Biomedicine Group for Acute Respiratory Distress Syndrome: Likelihood of Approval
Mesenchymal Stem Cells-Derived Exosomes is under clinical development by Cellular Biomedicine Group and currently in Phase II for Acute Respiratory...
Mesenchymal Stem Cells-Derived Exosomes by Cellular Biomedicine Group for Dermatomyositis: Likelihood of Approval
Mesenchymal Stem Cells-Derived Exosomes is under clinical development by Cellular Biomedicine Group and currently in Phase II for Dermatomyositis. According...
Mesenchymal Stem Cells-Derived Exosomes by CellTex Therapeutics for Alzheimer's Disease: Likelihood of Approval
Mesenchymal Stem Cells-Derived Exosomes is under clinical development by CellTex Therapeutics and currently in Phase I for Alzheimer's Disease. According...